In Vitro and In Vivo Biocompatibility of Bacterial Cellulose
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024-10 · 112 (10)
DOI: 10.1002/jbm.b.35488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 03.10.2024. Verfasst von Vincent-Daniel Girard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de bio-ingénierie et de biophysique de l'Université de Sherbrooke, Department of Chemical and Biotechnological Engineering, Université de…. Hauptthemen laut MEDLINE: Cellulose, Rats, Sprague-Dawley, Materials Testing. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs.
Abstract (Originalsprache)
Bacterial cellulose is a unique biomaterial produced by various species of bacteria that offers a range of potential applications in the biomedical field. To provide a cost‐effective alternative to soft‐tissue implants used in cavity infills, remodeling, and subdermal wound healing, in vitro cytotoxicity and in vivo biocompatibility of native bacterial cellulose were investigated. Cytotoxicity was assessed using a metabolic assay on Swiss 3T3 fibroblasts and INS‐1832/13 rat insulinoma. Results showed no cytotoxicity, whether the cells were seeded over or under the bacterial cellulose scaffolds. Biocompatibility was performed on Sprague–Dawley rats (males and females, 8 weeks old) by implanting bacterial cellulose membranes subcutaneously for 1 or 12 weeks. The explanted scaffolds were then sliced and stained with hematoxylin and eosin for histological characterization. The first series of results revealed acute and chronic inflammation persisting over 12 weeks. Examination of the explants indicated a high number of granulocytes within the periphery of the bacterial cellulose, suggesting the presence of endotoxins within the membrane, confirmed by a Limulus amebocyte lysate test. This discovery motivated the development of non‐pyrogenic bacterial cellulose scaffolds. Following this, a second series of animal experiments was done, in which materials were implanted for 1 or 2 weeks. The results revealed mild inflammation 1 week after implantation, which then diminished to minimal inflammation after 2 weeks. Altogether, this study highlights that unmodified, purified native bacterial cellulose membranes may be used as a cost‐effective biomedical device provided that proper endotoxin clearance is achieved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de bio-ingénierie et de biophysique de l'Université de Sherbrooke, Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, Québec, Canada.
- Centre de recherche du CHUS, Faculté de médecine et des sciences de la santé, Québec, Canada.
- AxCell Laboratories, Québec, Canada.
- Department of Pathology, Université de Sherbrooke, Faculté de médecine et des sciences de la santé, Québec, Canada.
- Department of Surgery, Université de Sherbrooke, Faculté de médecine et des sciences de la santé, Québec, Canada.
ORCID-Profile: Patrick Vermette
Förderung
- Mitacs
Zitieren
APA
Girard, V. D., Chaussé, J., Borduas, M., Dubuc, É., Iorio-Morin, C., Brisebois, S., & Vermette, P. (2024). In Vitro and In Vivo Biocompatibility of Bacterial Cellulose. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 112(10). https://doi.org/10.1002/jbm.b.35488
Vancouver
Girard VD, Chaussé J, Borduas M, Dubuc É, Iorio-Morin C, Brisebois S, et al. In Vitro and In Vivo Biocompatibility of Bacterial Cellulose. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024;112(10). doi:10.1002/jbm.b.35488
BibTeX
@article{Girard2024,
author = {Girard, Vincent-Daniel and Chaussé, Jérémie and Borduas, Martin and Dubuc, Émile and Iorio-Morin, Christian and Brisebois, Simon and Vermette, Patrick},
title = {In Vitro and In Vivo Biocompatibility of Bacterial Cellulose},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2024},
volume = {112},
number = {10},
doi = {10.1002/jbm.b.35488}
}
EUVIMED